You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RET altered

Showing 1 - 25 of 2,095
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

Not yet recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +3 more
  • Chang chun, Jilin, China
    Jinlin Province Cancer Hosipital
Dec 21, 2022

Advanced Solid Tumor Trial in Los Angeles (EP0031)

Recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +3 more
Dec 1, 2022

Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston

Recruiting
  • Malignant Thyroid Gland Neoplasm
  • +6 more
  • Quality-of-Life Assessment
  • +3 more
  • Ann Arbor, Michigan
  • +1 more
Jan 24, 2023

RET-altered Solid Tumors Trial in Shanghai (APS03118)

Recruiting
  • RET-altered Solid Tumors
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Dec 8, 2022

NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Shanghai, Shanghai, China
  • +1 more
Mar 17, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Advanced Nonhaematologic Malignancies Trial in Worldwide (BOS172738)

Active, not recruiting
  • Advanced Nonhaematologic Malignancies
  • Philadelphia, Pennsylvania
  • +20 more
Sep 23, 2022

NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Scottsdale, Arizona
  • +84 more
Oct 10, 2022

Aging, Sarcopenia Trial in Derby (High intensity interval training (HIIT), Resistance based training (RET))

Recruiting
  • Aging
  • Sarcopenia
  • High intensity interval training (HIIT)
  • Resistance based training (RET)
  • Derby, Derbyshire, United Kingdom
    Graduate Entry Medical School, University of Nottingham, Royal D
Jul 6, 2023

Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

Recruiting
  • Nonsmall Cell Lung Cancer
  • HS-10365 capsules
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 22, 2023

Children and Adults With Medullary Thyroid Cancer

Recruiting
  • Medullary Thyroid Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 7, 2022

    Hypertrophy, Muscle Strength, High-Intensity Interval Training Trial (Low Load Resistance training, Sprint/High Intensity

    Not yet recruiting
    • Hypertrophy
    • +3 more
    • Low Load Resistance training
    • Sprint/High Intensity Interval Training
    • (no location specified)
    Jul 11, 2023

    NSCLC Trial in Shanghai (SY-5007)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Sep 4, 2023

    Refractory Solid Tumors Trial in Seoul (sunitinib)

    Completed
    • Refractory Solid Tumors
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

    Active, not recruiting
    Has Results
    • Solid Tumor
    • Medullary Thyroid Cancer
    • Guangzhou, Guangdong, China
    • +12 more
    May 9, 2022

    MDD Trial in Ames (Resistance Exercise Training)

    Active, not recruiting
    • Major Depressive Disorder
    • Resistance Exercise Training
    • Ames, Iowa
      Iowa State University
    Jan 12, 2023

    Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +37 more
    • Birmingham, Alabama
    • +171 more
    Aug 24, 2022

    Stroke Trial (Power-focused resistance training)

    Not yet recruiting
    • Stroke
    • Power-focused resistance training
    • (no location specified)
    Apr 18, 2023

    NSCLC, Thyroid Tumors Trial (LOXO-260)

    Temporarily not available
    • Carcinoma, Non-Small-Cell Lung
    • Thyroid Neoplasms
    • (no location specified)
    Sep 20, 2022

    Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer Trial in Singapore (Oral lenvatinib + Intravenous (IV)

    Not yet recruiting
    • Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
    • Oral lenvatinib + Intravenous (IV) pembrolizumab + Oral letrozole
    • Singapore, Singapore
      National Cancer Centre Singapore
    Oct 13, 2022

    Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

    Not yet recruiting
    • Thyroid Cancer
    • +5 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Dec 20, 2022

    NSCLC Trial in Guangzhou (HA121-28 tablet)

    Recruiting
    • NSCLC
    • HA121-28 tablet
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Centre
    Aug 2, 2022

    Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation Trial in Korea, Republic of, United States (TPX-0046)

    Recruiting
    • Non Small Cell Lung Cancer
    • +4 more
    • Irvine, California
    • +15 more
    Mar 9, 2022

    Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Tampa

    Recruiting
    • Lung Non-Small Cell Carcinoma
    • +4 more
    • Tampa, Florida
      Moffitt Cancer Center
    Aug 16, 2022

    Eyes With Non Proliferative Diabetic Retinopathy in Diabetes

    Recruiting
    • NPDR - Non Proliferative Diabetic Retinopathy
    • +2 more
    • Biomarkers
    • Dijon, France
    • +4 more
    Jul 18, 2022